Multiparameter flow cytometry for the characterization of human embryonic stem cells

Biotechnology Letters

Volumn 35, Issue 1, 2013, Pages 55-65

  Brosnan, Kathryn ^a   Want, Andrew ^a   Coopman, Karen ^a   Hewitt, Christopher J ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Human embryonic stem cells; Isotype control; Multiparameter flow cytometry; SSEA 1; SSEA 4; Tra 1 60

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; FLOW CYTOMETRY;

HUMAN EMBRYONIC STEM CELLS; MULTI-PARAMETER FLOW CYTOMETRY; SSEA 1; SSEA 4; TRA-1-60;

STEM CELLS;

EID: 84870580516     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-012-1052-y     Document Type: Article

References (36)

1. Adachi K, Hirofumi S, Yasuda S, Nakatsuji N, Kawase E (2010) Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 15: 455-469.
2. Allegrucci C, Young LE (2007) Differences between human embryonic stem cell lines. Hum Reprod Update 13: 103-120.
3. Allegrucci C, Denning CN, Burridge P, Steele W, Sinclair KD, Young LE (2005) Human embryonic stem cells as a model for nutritional programming: an evaluation. Reprod Toxicol 20: 353-367.
4. Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J, Keitz A, Looijenga LHJ, Millian JL, Oosterhuis JW, Pera M, Sawada M, Schmoll HJ, Skakkebaek NE, Putten W, Stern P (1996) Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 66: 806-808.
5. Barraud P, Stott S, MØllgard K, Parmar M, Björklund A (2007) In vitro characterisation of a human neural progenitor cell coexpressing SSEA 4 and CD133. J Neurosci Res 85: 250-259.
6. Brimble SN, Sherrer ES, Uhl EW, Wang E, Kelly S, Merrill AH, Robins AJ, Schulz TC (2007) The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 25: 54-62.
7. Cai J, Chen J, Liu Y, Miura T, Luo Y, Loring JF, Freed WJ, Rao MS, Zeng X (2006) Assessing self-renewal and differentiation in hESC lines. Stem Cells 24: 516-530.
8. Carpenter MK, Rosler ES, Fisk GJ, Brandenberger R, Ares X, Miura T, Lucero M, Rao MS (2004) Properties of four human embryonic stem cell lines maintained in a feeder free culture system. Dev Dyn 229: 243-258.
9. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
10. Czechowska K, Johnson DR, van der Meer JR (2008) Use of flow cytometry for single cell analysis in environmental microbiology. Curr Opin Microbiol 11: 205-212.
11. De Rosa SC, Brenchley JM, Roederer M (2003) Beyond six colors: a new era in flow cytometry. Nat Med 9: 112-117.
12. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8: 315-317.
13. Draper JS, Pigott C, Thomson JA, Andrews PW (2002) Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200: 249-258.
14. Fong H, Hohenstein K, Donovan PJ (2008) Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26: 1931-1938.
15. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RCR (2007) SSEA 4 identifies mesenchymal stem cells for bone marrow. Stem Cells Hematol 109: 1743-1751.
16. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, Andrews PW (2002) Pre-implantation human embryos and embryonic stem cells show comparable expression of stage specific embryonic antigens. Stem Cells 20: 329-337.
17. Hoffman LM, Carpenter MK (2005) Characterization and culture of human embryonic stem cells. Nat Biotechnol 23: 699-708.
18. International Stem Cell Initiative (2007) Characterisation of human embryonic stem cell lines by the international stem cell initiative. Nat Biotechnol 25: 803-816.
19. Jansen K, Blimkie D, Furlong J, Hajjar A, Rein-Weston A, Crabtree J, Reikie B, Wilson C, Kollmann T (2008) Polychromatic flow cytometric high-throughput assay to analyze the innate immune response to Toll-like receptor stimulation. J Immunol Methods 336: 183-192.
20. Laslett AL, Filipczyk AA, Pera MF (2003) Characterisation and culture of human embryonic stem cells. Trends Cardiovasc Med 13: 295-301.
21. Liang YJ, Kuo HH, Lin CH, Chen YY, Yang BC, Cheng YY, Yu AL, Kho KH, Yu J (2010) Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation. Proc Natl Acad Sci USA 107(52): 22564-22569.
22. Linju-Yen B, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC (2005) Isolation of multi-potent cells from human term placenta. Stem Cells 23: 3-9.
23. Medvedev SP, Shevchenko AI, Mazurok NA, Zakian SM (2008) OCT4 and NANOG are the key genes in the system of pluripotency maintenance in mammalian cells. Russ J Genet 44: 1377-1393.
24. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, SchÖler H, Smith A (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391.
25. Preffer F, Dombkowski D (2009) Advances in multiparameter flow cytometry technology: applications in stem cell research. Cytometry B Clin Cytom 76: 295-314.
26. Prowse ABJ, Wilson J, Osborne GW, Gray PP, Wolvetang EJ (2009) Multi-plexed staining of live human embryonic stem cells for flow cytometry analysis of pluripotency markers. Stem Cells Dev 18: 1135-1140.
27. Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O (2007) Markers and methods for cell sorting of human embryonic stem cell derived neural cell populations. Stem Cells 25(9): 2257-2268.
28. Ramirez JM, Gerbal-Chaloin S, Milhavet O, Bai Q, Becker F, Assou S, Lemaître JM, Hamamah S, De Vos J (2011) Benchmarking human pluripotent stem cell markers during differentiation into the three germ layers unveils a striking heterogeneity: all markers are not equal. Stem Cells 29: 1469-1474.
29. Schinzel RT, Ahfeldt T, Lau FH, Lau YK, Cowley A, Shen T, Peters D, Lum DH, Cowan CA (2011) Efficient culturing and genetic manipulation of human pluripotent stem cells. PLoS One 6(12): 1-6.
30. Shapiro HM (1983) Multistation multiparameter flow cytometry: a critical review and rationale. Cytometry 3: 227-242.
31. Strain E, Hahne F, Brinkman RR, Haaland P (2009) Analysis of high throughput flow cytometry data using platecore. Adv Bioinformatics 356141: 1-10.
32. Thomas RJ, Anderson D, Chandra A, Smith NM, Young LE, Williams D, Denning C (2009) Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol Bioeng 102: 1636-1644.
33. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
34. MRC, UK Stem Cell Line Registry [Internet], Issued 2008. http://www. mrc. ac. uk/consumption/groups/public/documents/content/mrc003259. pdf. Accessed June 7 2012.
35. Want AJ, Nienow AW, Hewitt CJ, Coopman K (2012) Large scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: beyond the T flask. Regen Med 7: 71-84.
36. Wright AJ, Andrews PW (2009) Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Res 3: 3-11.